Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Cytogenetic biomarkers and genetic polymorphisms.

Norppa H.

Toxicol Lett. 2004 Apr 1;149(1-3):309-34. Review.

PMID:
15093278
2.

Cytogenetic biomarkers.

Norppa H.

IARC Sci Publ. 2004;(157):179-205. Review.

PMID:
15055296
3.
4.

[Biomarkers of gentotoxic risk and metabolic polymorphism].

Pavanello S, Clonfero E.

Med Lav. 2000 Sep-Oct;91(5):431-69. Review. Italian.

PMID:
11189784
5.

Biological indicators of genotoxic risk and metabolic polymorphisms.

Pavanello S, Clonfero E.

Mutat Res. 2000 Oct;463(3):285-308. Review.

PMID:
11018745
6.

Genetic polymorphisms and chromosome damage.

Norppa H.

Int J Hyg Environ Health. 2001 Oct;204(1):31-8. Review.

PMID:
11725342
7.

Chromosomal aberrations and SCEs as biomarkers of cancer risk.

Norppa H, Bonassi S, Hansteen IL, Hagmar L, Strömberg U, Rössner P, Boffetta P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabiánová E, Srám RJ, Knudsen LE, Barale R, Fucic A.

Mutat Res. 2006 Aug 30;600(1-2):37-45. Epub 2006 Jul 11. Review.

PMID:
16814813
8.

Genetic susceptibility, biomarker respones, and cancer.

Norppa H.

Mutat Res. 2003 Nov;544(2-3):339-48. Review.

PMID:
14644336
9.

[Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].

Pavanello S, Clonfero E.

G Ital Med Lav Ergon. 2004 Oct-Dec;26(4):311-21. Review. Italian.

PMID:
15584438
10.

Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects.

Srám RJ.

Environ Health Perspect. 1998 Feb;106 Suppl 1:231-9. Review.

11.

Genetic effects and biotoxicity monitoring of occupational styrene exposure.

Rueff J, Teixeira JP, Santos LS, Gaspar JF.

Clin Chim Acta. 2009 Jan;399(1-2):8-23. doi: 10.1016/j.cca.2008.09.012. Epub 2008 Sep 20. Review.

PMID:
18845133
12.

Genetic polymorphisms and micronucleus formation: a review of the literature.

Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T.

Mutat Res. 2008 Mar-Apr;658(3):215-33. Epub 2007 Oct 22. Review.

PMID:
18037339
13.

XRCC1 polymorphism and lung cancer risk.

Schneider J, Classen V, Helmig S.

Expert Rev Mol Diagn. 2008 Nov;8(6):761-80. doi: 10.1586/14737159.8.6.761. Review.

PMID:
18999926
14.
15.

Molecular epidemiology in cancer research.

Collins AR.

Mol Aspects Med. 1998 Dec;19(6):359-432. Review.

PMID:
10385877
16.

[Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies].

Habdous M, Siest G, Herbeth B, Vincent-Viry M, Visvikis S.

Ann Biol Clin (Paris). 2004 Jan-Feb;62(1):15-24. Review. French.

17.

Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999.

Srám RJ, Binková B.

Environ Health Perspect. 2000 Mar;108 Suppl 1:57-70. Review.

18.
19.

Environmental and chemical carcinogenesis.

Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.

Semin Cancer Biol. 2004 Dec;14(6):473-86. Review.

PMID:
15489140
20.

DNA repair and cyclin D1 polymorphisms and styrene-induced genotoxicity and immunotoxicity.

Kuricova M, Naccarati A, Kumar R, Koskinen M, Sanyal S, Dusinska M, Tulinska J, Vodickova L, Liskova A, Jahnova E, Fuortes L, Haufroid V, Hemminki K, Vodicka P.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):302-9. Review.

PMID:
15992842

Supplemental Content

Support Center